- Masimo, the company that sued Apple over patent infringement, has unveiled its own blood oxygen monitoring smartwatch called the Masimo Freedom.
- The Masimo Freedom is a health-focused device that can track blood oxygen levels, hydration index, respiration rate, pulse rate variability, pulse rate, steps, and detect falls.
- The smartwatch is currently in prototype stage and will be available for sale later this year at a price of $999.
Archive link: https://archive.ph/aOUXX
I feel like they’d have made more money by licensing their patent to Apple rather than trying to sell a watch for a ridiculous $999 price tag. I’m not saying they were wrong for their patent lawsuit, and it’s nice to see that small companies can still win, but I just don’t see this early product getting enough sales for them to profit.
I might be mistaken, but I think Apple started with a licensing deal and then walked back on it?
Googled and found this
https://news.ycombinator.com/item?id=38774769